newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Present at Jefferies London Healthcare Conference

CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada", "the Company")), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),